共 34 条
[1]
ANDERSON W.F., Human gene therapy, Science, 256, pp. 808-813, (1992)
[2]
BADER D., MASAKl T., FISCHMAN D.A., Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro, J. Cell. Biol., 95, pp. 763-770, (1982)
[3]
BARR E., LEIDEN J.M., Systemic delivery of recombinant proteins by genetically modified myoblasts, Science, 254, pp. 1507-1509, (1991)
[4]
CONSTANTINIDES P.O., JONES P.A., GEVERS W., Functional striated muscle cells from nonmyoblast precursors following 5-azacytidine treatment, Nature, 267, pp. 364-366, (1977)
[5]
COUTURE L.A., MULLEN C.A., MORGAN R.A., Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression, Hum. Gene Ther., 5, pp. 667-677, (1994)
[6]
DAI Y., ROMAN M., NAVIAUX R.K., VERMA I.M., Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo, Proc. Natl. Acad. Sci., 89, pp. 10892-10895, (1992)
[7]
DANKO I., FRITZ J.D., LATENDRESSE J.S., HERWEIJER H., SCHULTZ E., WOLFF J.A., Dystrophin expression improves myofiber survival in Mdx muscle following intramuscular plasmid DNA injection, Hum. Mol. Genet., 2, pp. 2055-2061, (1993)
[8]
DAVIS B., LINNEY E., FAN H., Suppression of leukaemia virus pathogenicity by polyoma virus enhancers, Nature, 314, pp. 550-553, (1985)
[9]
DAVIS H.L., DEMENEIX B.A., QUANTIN B., COULOMBE J., WHALEN R.G., Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle, Hum. Gene Ther., 4, pp. 733-740, (1993)
[10]
DHAWAN J., PAN L.C., PAVLATH G.K., TRAVIS M.A., LANCTOT A.M., BLAU H.M., Systemic delivery of human growth hormone by injection of genetically engineered myoblasts, Science, 254, pp. 1509-1512, (1991)